Skip to content

Pharminent

cropped-neurology_aaic_banner_frontpage_2026-07-15-1.png
Primary Menu
  • Home
  • Signal News
  • Biopharma Brief
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Interactive Calendar
    • Manufacturing Intelligence
  • Contact
Light/Dark Button
Brief
  • Home
  • Manufacturing
  • Eisai claims UK grant to expand manufacturing site
  • Manufacturing

Eisai claims UK grant to expand manufacturing site

Pharmaphorum

Eisai has been given a grant from the UK that will support a 48m plan to add cold chain capabilities to its facility in Hatfield, Hertfordshire.

Read full story

pharminent June 15, 2026 (Last updated: June 15, 2026)

Pharmaphorum

Eisai has been given a grant from the UK that will support a 48m plan to add cold chain capabilities to its facility in Hatfield, Hertfordshire.

Read full story

Sign up to receive free daily digest

Check your inbox or spam folder to confirm your subscription.

Post navigation

Previous: Key pipeline drug for Lundbeck delivers in Cushing syndrome
Next: FDA and MHRA forge new regulatory collaboration initiative

Related Stories

  • Manufacturing

Lilly and Resilience invest $750M in diabetes and obesity drug device supply

pharminent July 31, 2026
  • Manufacturing

GSK Cambridge Move Signals Shift in Drug Scale-Up Strategy

pharminent July 29, 2026
  • Manufacturing

GSK to quit Stevenage for new R&D site in Cambridge

pharminent July 28, 2026
© 2026 All rights reserved. | ReviewNews by AF themes.